Divergence in Fitness and Evolution of Drug Resistance in Experimental Populations of Candida albicans

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Bacteriology

• Publication date

  2001-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JB.183.10.2971-2978.2001PMID 11325923PMCID PMC95195
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The cost of antibiotic resistance--from the perspective of a bacterium.

  2007cited by this paper
• Single-Copy IMH3 Allele Is Sufficient To Confer Resistance to Mycophenolic Acid in Candida albicans and To Mediate Transformation of Clinical Candida Species

  2001cited by this paper
• Clonal and Spontaneous Origins of Fluconazole Resistance in Candida albicans

  2000cited by this paper
• Evolution of Drug Resistance in Experimental Populations of Candida albicans

  2000cited by this paper
• Recent developments in molecular genetics of Candida albicans.

  2000cited by this paper
• Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria.

  2000cited by this paper
• Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance.

  2000cited by this paper
• Mice Are Not Furry Petri Dishes

  2000cited by this paper
• Fitness of Botrytis cinerea Associated with Dicarboximide Resistance.

  2000cited by this paper
• The cost of antibiotic resistance from a bacterial perspective.

  2000cited by this paper
• Perspectives: microbiology. Mice are not furry petri dishes.

  2000cited by this paper
• The impact of antibiotic use on resistance development and persistence.

  2000cited by this paper
• The Trailing End Point Phenotype in Antifungal Susceptibility Testing Is pH Dependent

  1999cited by this paper
• Parallel evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection.

  1999cited by this paper
• Disease transmission dynamics and the evolution of antibiotic resistance in hospitals and communal settings.

  1999cited by this paper
• The biological cost of antibiotic resistance.

  1999cited by this paper
• The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance.

  1999cited by this paper
• Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy.

  1999cited by this paper
• Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy.

  1998cited by this paper
• Antifungals: mechanism of action and resistance, established and novel drugs.

  1998cited by this paper
• Evolution of competitive fitness in experimental populations of E. coli: What makes one genotype a better competitor than another?

  1998cited by this paper
• Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance

  1998cited by this paper
• Adaptation to the fitness costs of antibiotic resistance in Escherichia coli

  1997cited by this paper
• Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Labora

  1997cited by this paper
• The population genetics of antibiotic resistance.

  1997cited by this paper
• The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally.

  1997cited by this paper
• Genetic divergence and fitness convergence under uniform selection in experimental populations of bacteria.

  1996cited by this paper
• Long-term experimental evolution in Escherichia coli. IV. Targets of selection and the specificity of adaptation.

  1996cited by this paper
• Fitness of isolates of Erysiphe graminis f.sp. tritici with reduced sensitivity to fenpropimorph.

  1996cited by this paper
• Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drug.

  1996cited by this paper
• Experimental tests of the roles of adaptation, chance, and history in evolution.

  1995cited by this paper
• Resistance of Candida species to fluconazole

  1995cited by this paper
• Long-Term Experimental Evolution in Escherichia coli. II. Changes in Life-History Traits During Adaptation to a Seasonal Environment

  1994cited by this paper
• Lack of correlation between fitness and resistance to sterol biosynthesis-inhibiting fungicides in Pyrenophora teres

  1994cited by this paper
• AMELIORATION OF THE DELETERIOUS PLEIOTROPIC EFFECTS OF AN ADAPTIVE MUTATION IN BACILLUS SUBTILIS

  1994cited by this paper
• Human mycoses: drugs and targets for emerging pathogens.

  1994cited by this paper
• Balancing the drug-resistance equation.

  1994cited by this paper
• Dynamics of adaptation and diversification: a 10,000-generation experiment with bacterial populations.

  1994cited by this paper
• Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review.

  1992cited by this paper
• Long-Term Experimental Evolution in Escherichia coli. I. Adaptation and Divergence During 2,000 Generations

  1991cited by this paper
• Surfaces of Selective Value Revisited

  1988cited by this paper
• Evolution of a bacteria/plasmid association

  1988cited by this paper
• Relative fitness can decrease in evolving asexual populations of S. cerevisiae

  1983cited by this paper
• CHARACTER CHANGE, SPECIATION, AND THE HIGHER TAXA

  1982cited by this paper
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper

• Experimental Evolution of Pathogenic Candida spp.: Insights into Adaptive Processes and Evolutionary Dynamics.

  2026cites this paper
• The Role of Drug Resistance in Candida Inflammation and Fitness

  2025cites this paper
• Unlocking the potential of experimental evolution to study drug resistance in pathogenic fungi

  2024cites this paper
• Assessing the predictability of fungicide resistance evolution through in vitro selection

  2024cites this paper
• Comparative fitness trade-offs associated with azole resistance in Candida auris clinical isolates

  2024cites this paper
• Nothing makes sense in drug resistance except in the light of evolution.

  2023cites this paper
• Analysis of Candida Antifungal Resistance Using Animal Infection Models.

  2023cites this paper
• Tetraploidy accelerates adaptation under drug selection in a fungal pathogen

  2022cites this paper
• Experimental and in-host evolution of triazole resistance in human pathogenic fungi

  2022cites this paper
• The Hydrophobin Gene Family Confers a Fitness Trade-off between Spore Dispersal and Host Colonization in Penicillium expansum

  2022cites this paper
• Directed evolution predicts cytochrome b G37V target site modification as probable adaptive mechanism towards the QiI fungicide fenpicoxamid in Zymoseptoria tritici

  2021cites this paper
• Resistance to Antifungal Drugs.

  2021cites this paper
• Diversity of acquired adaptation to fluconazole is influenced by genetic background and ancestral fitness in ​ Candida

  2020cites this paper
• Role of Antifungal Drugs in Combating Invasive Fungal Diseases

  2019cites this paper
• Global Screening of Genomic and Transcriptomic Factors Associated with Phenotype Differences between Multidrug-Resistant and -Susceptible Candida haemulonii Strains

  2019cites this paper
• Mechanisms of genome evolution in Candida albicans.

  2019cites this paper
• Aurora kinase Ipl1 facilitates bilobed distribution of clustered kinetochores to ensure error-free chromosome segregation in Candida albicans

  2019cites this paper
• Fitness Penalties in the Evolution of Fungicide Resistance.

  2018cites this paper
• Feedback between environment and traits under selection in a seasonal environment: consequences for experimental evolution

  2018cites this paper
• Modélisation des dynamiques adaptatives de la levure de boulanger S. cerevisae dans un environnement saisonnier

  2018cites this paper
• Genetic background influences heterogeneity of adaptive response and genome stability during prolonged antifungal drug exposure in Candida albicans

  2018cites this paper
• Population structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait

  2017cites this paper
• Longitudinal genomic surveillance of Plasmodium falciparum malaria parasites reveals complex genomic architecture of emerging artemisinin resistance

  2017cites this paper
• Fungal adaptation to contemporary fungicide applications: the case of Botrytis cinerea populations from Champagne vineyards (France)

  2017cites this paper
• Longitudinal genomic surveillance of Plasmodium falciparum malaria parasites reveals complex genomic architecture of emerging artemisinin resistance in western Thailand

  2016cites this paper
• Ploidy dynamics and evolvability in fungi

  2016cites this paper
• La localité d’échantillonnage influence-t-elle l’activité antifongique des flavonoïdes de Marrubium vulgare vis-à-vis de Aspergillus niger et Candida albicans ?

  2016cites this paper
• [Does the sampling locality influence on the antifungal activity of the flavonoids of Marrubium vulgare against Aspergillus niger and Candida albicans?].

  2016cites this paper
• Experimental evolution in fungi: An untapped resource.

  2016cites this paper
• A Population Genomics Approach to Assessing the Genetic Basis of Within-Host Microevolution Underlying Recurrent Cryptococcal Meningitis Infection

  2016cites this paper
• Candida survival strategies.

  2015cites this paper
• QTL mapping of fungicide sensitivity reveals novel genes and pleiotropy with melanization in the pathogen Zymoseptoria tritici.

  2015cites this paper
• Isolated cell behavior drives the evolution of antibiotic resistance

  2015cites this paper
• Tipping the balance both ways: drug resistance and virulence in Candida glabrata.

  2015cites this paper
• The role of cooperation and dispersal in the evolution of antibiotic resistance

  2015cites this paper
• Antifungal drug resistance among Candida species: mechanisms and clinical impact

  2015cites this paper
• Determining the Mechanisms of Resistance to Drug Combinations and their Fitness Effects in Candida albicans

  2014cites this paper
• Antifungal resistance does not necessarily affect Candida glabrata fitness

  2014cites this paper
• Microevolution of Antifungal Drug Resistance

  2014cites this paper
• Fine-Scale Chromosomal Changes in Fungal Fitness

  2014cites this paper
• Genetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations

  2013cites this paper
• Evolution of pleiotropic costs in experimental populations

  2013cites this paper
• A Competitive Infection Model of Hematogenously Disseminated Candidiasis in Mice Redefines the Role of Candida albicans IRS4 in Pathogenesis

  2013cites this paper
• Serial Passaging of Candida albicans in Systemic Murine Infection Suggests That the Wild Type Strain SC5314 Is Well Adapted to the Murine Kidney

  2013cites this paper
• Characterization of European Plasmopara viticola isolates with reduced sensitivity to cymoxanil

  2013cites this paper
• Distinct Roles of Candida albicans Drug Resistance Transcription Factors TAC1, MRR1, and UPC2 in Virulence

  2013cites this paper
• Evolution of Drug Resistance in Fungi

  2013cites this paper
• Constraints on the evolution of azole resistance in plant pathogenic fungi

  2013cites this paper
• The Role of Fungal Stress Responses in Regulation of Azole Resistance

  2013cites this paper
• The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans

  2012cites this paper
• Evidence for genetic differentiation and variable recombination rates among Dutch populations of the opportunistic human pathogen Aspergillus fumigatus

  2012cites this paper
• The Roles of Hsp90 and Calcineurin in Antifungal Drug Resistance

  2012cites this paper
• A characterization of adaptive mutations in yeast

  2012cites this paper
• The Impact of Antifungal Drug Resistance in the Clinic

  2012cites this paper
• In Vitro Evolutionary Dynamics of C. albicans during Adaptation to Fluocnazole

  2012influential citation
• Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata

  2012cites this paper
• Candida glabrata: Multidrug Resistance and Increased Virulence in a Major Opportunistic Fungal Pathogen

  2012cites this paper
• Population dynamics and the evolution of antifungal drug resistance in Candida albicans.

  2012cites this paper
• At what cost echinocandin resistance?

  2011cites this paper
• Chemosensitization of Aflatoxigenic Fungi to Antimycin A and Strobilurin Using Salicylaldehyde, a Volatile Natural Compound Targeting Cellular Antioxidation System

  2011cites this paper
• Evolutionary Dynamics of Candida albicans during In Vitro Evolution

  2011cites this paper
• Cryptic Fitness Advantage: Diploids Invade Haploid Populations Despite Lacking Any Apparent Advantage as Measured by Standard Fitness Assays

  2011cites this paper
• Diversity and fitness of Plasmopara viticola isolates resistant to QoI fungicides

  2011cites this paper
• Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.

  2011cites this paper
• Regulatory Circuitry Governing Fungal Development, Drug Resistance, and Disease

  2011cites this paper
• Difference in virulence between fluconazole‐susceptible and fluconazole‐resistant Candida albicans in a mouse model

  2011cites this paper
• Population biological principles of drug-resistance evolution in infectious diseases.

  2011cites this paper
• Stress Alters Rates and Types of Loss of Heterozygosity in Candida albicans

  2011cites this paper
• Compensation of Fitness Costs and Reversibility of Antibiotic Resistance Mutations

  2010cites this paper
• The quorum‐sensing molecule E,E‐farnesol—its variable secretion and its impact on the growth and metabolism of Candida species

  2010cites this paper
• On the evolution of pesticide resistance in Phytophthora infestans : an experimental evolution approach

  2009cites this paper
• Acquisition of Aneuploidy Provides Increased Fitness during the Evolution of Antifungal Drug Resistance

  2009cites this paper
• Efflux-Mediated Antifungal Drug Resistance

  2009cites this paper
• Genetic basis of antifungal drug resistance

  2009cites this paper
• Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence

  2009cites this paper
• Will resistance in fungi emerge on a scale similar to that seen in bacteria?

  2008cites this paper
• Increase of Virulence and Its Phenotypic Traits in Drug-Resistant Strains of Candida albicans

  2008cites this paper
• Mixed Candida albicans strain populations in colonized and infected mucosal tissues

  2008cites this paper
• Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance

  2008cites this paper
• Multilocus Sequence Typing of Pathogenic Candida Species

  2008cites this paper
• Chemosensitizationoffungal pathogens toantimicrobial agents using benzoanalogs

  2008cites this paper
• The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype

  2008cites this paper
• Chemosensitization of fungal pathogens to antimicrobial agents using benzo analogs.

  2008cites this paper
• Multilocus Sequence Typing of Pathogenic Candida Species

  2008cites this paper
• Enhancement of fludioxonil fungicidal activity by disrupting cellular glutathione homeostasis with 2,5-dihydroxybenzoic acid.

  2007cites this paper
• At Least Two Origins of Fungicide Resistance in Grapevine Downy Mildew Populations

  2007cites this paper
• The genetic dissection of differential growth in Plasmodium falciparum and its relationship to chloroquine drug selection

  2007cites this paper
• Molecular principles of antifungal drug resistance.

  2006cites this paper
• In Vivo Fluconazole Pharmacodynamics and Resistance Development in a Previously Susceptible Candida albicans Population Examined by Microbiologic and Transcriptional Profiling

  2006cites this paper
• The Role of Compensatory Mutations in the Emergence of Drug Resistance

  2006cites this paper
• Reducing the cost of resistance; experimental evolution in the filamentous fungus Aspergillus nidulans

  2006cites this paper
• Candida albicans Strain Maintenance, Replacement, and Microvariation Demonstrated by Multilocus Sequence Typing

  2006cites this paper
• Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans

  2006cites this paper
• Overexpression of the 14α-Demethylase Target Gene (CYP51) Mediates Fungicide Resistance in Blumeriella jaapii

  2006cites this paper
• Evolution of antifungal-drug resistance: mechanisms and pathogen fitness

  2005cites this paper
• Correlation between in vitro growth rate and in vivo virulence in Aspergillus fumigatus.

  2005cites this paper
• Adaptation to the cost of resistance: a model of compensation, recombination, and selection in a haploid organism

  2005cites this paper
• Candida albicans switch phenotypes display differential levels of fitness.

  2004cites this paper
• Neurospora in temperate forests of western North America

  2004cites this paper
• Reducing fitness costs associated with antibiotic resistance: experimental evolution in the filamentous fungus Aspergillus nidulans

  2004influential citation